Showing results (161-170 of 2,957) with videos related to
Sort By:
Pageof 296
Molecular Medicine (Cambridge, Mass.)|January 19, 2023
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cellsTianming Zhao, Qiang He, Shurong Xie, et al.Molecular Medicine (Cambridge, Mass.)|January 20, 2023
Exploring the mechanism by which aqueous Gynura divaricata inhibits diabetic foot based on network pharmacology, molecular docking and experimental verificationYu Sun, Cailiang Gao, Huiting Liu, et al.Molecular Medicine (Cambridge, Mass.)|January 15, 2002
Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?F Zheng, W Cai, T Mitsuhashi, et al.Molecular Medicine (Cambridge, Mass.)|January 15, 2002
Nitric oxide inhibits endothelial IL-1[beta]-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activityD Berendji-Grün, V Kolb-Bachofen, K D KrönckeMolecular Medicine (Cambridge, Mass.)|January 15, 2002
Human endotoxemia activates p38 MAP kinase and p42/44 MAP kinase, but not c-Jun N-terminal kinaseB van den Blink, J Branger, S Weijer, et al.Molecular Medicine (Cambridge, Mass.)|January 15, 2002
Disruption of poly (ADP-ribose) polymerase (PARP) protects against stress-evoked immunocompromiseD L Drazen, D Bilu, N Edwards, et al.Molecular Medicine (Cambridge, Mass.)|January 10, 2002
The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentaeE G Zhang, S K Smith, P N Baker, et al.Molecular Medicine (Cambridge, Mass.)|October 31, 2001
Keratocan expression is increased in the stroma of keratoconus corneasK Wentz-Hunter, E L Cheng, J Ueda, et al.Molecular Medicine (Cambridge, Mass.)|December 29, 2000
Induction of skin fibrosis in mice expressing a mutated fibrillin-1 geneS Saito, H Nishimura, R G Phelps, et al.Molecular Medicine (Cambridge, Mass.)|December 29, 2000
Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatmentL Huang, A B PardeePageof 296